Matthew Falagas MD, MSc, DSc

RESEARCH INTERESTS

1. Antimicrobial resistance
2. Polymyxins
3. Nosocomial infections
4. Gram-negative bacterial infections(Acinetobacter, Pseudomonas, Klebsiella)
5. Infections in immunosuppressed patients
6. Estimates and determinants of research productivity
7. Medical education

RESEARCH GRANTS

2012 - 2013                 Antimicrobial activity of prulifloxacin (principal investigator)

2011                            Awareness of the clinical significance of C. difficile infection: an international survey  (principal investigator)

2010 - 2011                 Evaluation of the pharmacokinetic and pharmacodynamic properties and avtivity of trimethoprim-sulfametrol against pathogens (principal investigator)

2008 - 2010                 Evaluation of the in vitro avtivity of prulifloxacin against urinary and respiratory pathogens (principal investigator)

2006 - 2008                 Health literacy - informed consent (co-principal investigator)

2004 - 2005                 Biomedical research productivity of European countries (principal investigator)

2001 - 2003                 Long-term efficacy and safety of pioglitazone plus metformin versus gliclazide plus metformin in patients with type 2 diabetes mellitus (site principal investigator)

2000 - 2002                 Long-term efficacy and safety of pioglitazone versus metformin in          patients with type 2 diabetes mellitus (site principal investigator)

1998 - 1999                 Foundation of a database of Greek biomedical scientists in diaspora and its introduction in the world wide web (principal investigator)

1997                            Comparison of incidence and severity of toxicities of cyclosporine and recipients  (co-investigator)

1996 - 1997                 In vitro synergism between trovafloxacin and cefoperazone against Bacteroides fragilis group (co-investigator)

1996 - 1997                 Investigation of synergistic in vitro effect of trovafloxacin with cefoperazone or ceftazidime against Gram negative non-fermenting rods (co-investigator)

1996 - 1997                 Retrospective study examining independent risk factors for development of invasive Candida infections in surgical intensive care unit (SICU) patients (co-investigator)

1996                            Outcome of transplantation of solid organs from bacteremic donors (co-investigator)

1996                            Bacteriologic study examining the impact of pH on in vitro antimicrobial susceptibility of Bacteroides fragilis (co-investigator)

RESEARCH THESIS

"The impact of cytomegalovirus (CMV) on short and long term survival of orthotopic liver transplant recipients" (DSc), Athens University School of Medicine, Athens, Greece.

Mentor: Dr. Dimitrios Trichopoulos, Professor of Epidemiology, Athens University School of Medicine and Professor of Epidemiology, Harvard School of Public Health.

HONORS AND PRIZES

1997                            Maxwell Finland Young Investigator Award for Excellence in Research, Massachusetts Infectious Diseases Society

1997                            Research Award (for the study: Cancer incidence after metronidazole use: a matched metronidazole user/non-user study), Amfiaraion Foundation for the Study of Chemotherapeutic Agents, 23rd Panhellenic Medical Conference, Athens, Greece

1994                            Edward Kass Award for Clinical Excellence, Massachusetts Infectious Diseases Society

1992                            House Staff Award for Excellence in Teaching, The Medical Student Body  State University of New York (SUNY) at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York

1986                            Diploma in Medicine with “Excellence” (Top 1% of class), Athens University School of Medicine

1981 - 1986                 Scholarship, Athens University (1981 contest among candidate students from all Schools and Departments of Athens University)

1980                            First Prize, Greek National Mathematics Competition, Greek Association of Mathematicians

DISTINCTIONS

12/2007                       Distinction for the study “Readability of health related pamphlets distributed in hospitals and health centers in Athens”, 3^rd Pan-Hellenic Congress on Health Management, Economics, and Policy

09/2005                       Member of the National Faculty of “The Core Content Review of Family Medicine (USA)”

MEMBERSHIP

1. European Society of Clinical Microbiology and Infectious Diseases
2. Infectious Diseases Society of America
3. American Society for Microbiology
4. Massachusetts Medical Society
5. HIV Medicine Association
6. Medical Association of Athens
7. Hellenic Society of Infectious Diseases
8. Panhellenic Medical Association

LICENSURE AND CERTIFICATION

2001                            Certified Diplomate in Infectious Diseases (Greece)

1996                            Certified Diplomate in Internal Medicine (Greece)

1996                            Certified Diplomate in Infectious Diseases by the American Board of Internal Medicine (committee of Infectious Diseases) (USA)

1993                            Certified Diplomate in Internal Medicine by the American Board of Internal Medicine (USA)

1992                            Medical Licence in Massachusetts

1991                            USA Educational Commission for Foreign Medical Graduates (ECFMG) permanent certificate

1986                            Medical Licence in Greece

COMMITTEES

10/2007 – 4/2012        Professional Affairs Advisory Committee (Infectious Diseases), European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

10/2004 - 12/2005 &   President, Infection Control Committee, “Henry Dunant” Hospital, Athens,

01/2009 - 12/2009       Greece

05/2003 - contin.         Infection Control Committee, “Henry Dunant” Hospital, Athens, Greece

10/2001 - 9/2007         Education Committee, European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

10/1999 - 12/2002       Advisory Committee for the affiliation of “Hygeia” Hospital, Athens, Greece, with Partners HealthCare System (Massachusetts General Hospital, Brigham and Women’s Hospital and Dana Farber Cancer Institute), Boston, Massachusetts

06/1999 - 06/2000       External scientific partner, National Organization for Drugs, Athens, Greece

TASK_FORCE

2008 - 2010                 ECDC-CDC (European Center for Disease Prevention and Control - Center for Disease Prevention and Control) task force on definitions of multidrug-resistant Gram-negative bacilli